Common Errors in IND-enabling Toxicology Programs

In this podcast, we discuss 5 common errors in designing and managing IND-enabling toxicology programs with a special guest: Glenn Washer, EVP of Global Safety and Toxicology at Frontage Laboratories, Inc.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Common Errors in IND-enabling Toxicology Programs

Resources to Consider

STP 2025: Organ Weight Data Interpretation in Toxicology Studies

Safety and Toxicology Services Brochure

6 Reasons To Do Exploratory Toxicology for Successful GLP Studies

The role of genetic toxicology in drug development

Toxicology Services

Genetic Toxicology

Safety and Toxicology Virtual Tour

Human Gut Microbiome-Based Contract Research Applications in...

Before GLP: The Value of Robust Exploratory Toxicology

The Value Of Robust Exploratory Toxicology Testing Prior To Pivotal...

Best Practices in Managing IND Programs with CROs

No-observed-adverse-effect level (NOAEL) in IND Programs